Allurion Technologies Holdings Inc. has announced the publication of new long-term weight loss results from studies involving the Allurion Program. The findings, presented in publications, indicate that in a study of 522 patients, participants achieved an average weight loss of approximately 32 pounds at the time of balloon passage, with 95% of this weight loss maintained one year later. In a separate study involving 497 patients, the average weight loss was 14.3% of total body weight, with 86% of patients maintaining this weight loss one year after the initial treatment. These results highlight the potential of the Allurion Program in achieving and maintaining significant weight loss.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。